• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Akums Drugs & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 34484.0
  • ISIN : INE09XN01023
780.55 10 (1.34%)
  • As on 04 Sep 2026 (EOD)

  • Today’s Low

    760.50

  • Today’s High

    788.00

  • Open

    764.35

  • Perv Close

    770.25

  • 52W Low

    409.30

  • 52W High

    796.55

Key Indicators

  • P/E(TTM)

    105.60

  • Mar.Cap (₹Cr.)

    12,285.39

  • Div & Yield %

    0.37

  • Book Value(₹)

    154.29

  • Debt-Equity Ratio

    1.34

  • AGM Date

    03-Sep-2026

  • EPS

    7.40

  • P/E Ratio

    105.60

Financials Ratios

  • Debt-Equity Ratio

    0.83

  • Mar.Cap (₹Cr.)

    12,285.39

  • RONW (%)

    -2.22

  • ROCE (%)

    1.24

Score Board

  • Equity (₹ in Cr.)

    31.48

  • BV (₹)

    154.30

  • Sales( ₹ in Cr.)

    1,348.74

  • NP (in Cr.)

    116.52

  • NP Var(%)

    -26.0

  • Div%

    150.0

  • CPS (₹)

    10.30

  • EPS (₹)

    7.40

  • Traded Value (₹ in Lakhs)

    12,299.55

  • 52 Week High

    796.55

  • 52 Week Low

    409.30

  • Price BSE

    781.0

  • Price NSE

    781.00

  • Market Capital( in Cr.)

    12,299.55

  • P/C Ratio

    75.90

  • P/E Ratio

    105.50

  • Price Vs.BV

    7.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,348.74 1,311.78 1,444.12 1,286.83 1,162.06 837.44
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,348.74 1,311.78 1,444.12 1,286.83 1,162.06 837.44
Other Income 112.97 124.19 94.12 96.15 58.48 54.51
Stock Adjustments 3.26 10.05 -6.44 3.06 18.45 -10.64
Total Income 1,464.97 1,446.02 1,531.80 1,386.04 1,238.99 881.31
EXPENDITURE :            
Raw Materials 830.34 811.06 867.24 791.21 786.51 513.05
Power and Fuel Cost 49.64 45.36 42.40 42.04 36.25 28.64
Employee Cost 217.99 201.74 175.28 147.30 136.37 122.65
Other Manufacturing Expenses 68.15 68.18 62.69 42.04 62.62 51.89
Selling and Administration Expenses 42.19 25.73 31.90 22.33 16.82 13.80
Miscellaneous Expenses 52.73 31.27 404.21 147.63 503.99 319.56
Employee Benefit Expenses 217.99 201.74 175.28 147.30 136.37 122.65
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,261.05 1,183.34 1,583.73 1,192.54 1,542.55 1,049.59
Operating Profit 203.91 262.69 -51.93 193.50 -303.56 -168.28
Interest 10.04 15.31 18.31 13.18 3.65 0.82
Gross Profit 193.87 247.38 -70.24 180.32 -307.21 -169.10
Depreciation 45.50 39.55 32.69 30.00 27.76 26.10
Profit Before Tax 148.37 207.83 -102.93 150.32 -334.97 -195.20
Current Tax 36.40 49.66 62.52 41.00 0.34 6.40
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.32 -2.83 0.00 -16.11 46.46 -56.17
Reported Net Profit 111.64 161.00 -165.45 125.43 -381.78 -145.43
Extraordinary Items -4.88 2.61 -7.98 -105.11 0.99 -255.75
Adjusted Net Profit 116.52 158.39 -157.47 230.54 -382.77 110.32
Adjustment below Net Profit 0.47 861.44 -2.18 0.00 -11.62 0.16
P & L Balance brought forward 1,317.83 295.39 463.02 351.36 744.75 890.02
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 13.77 0.00 0.00
P & L Balance carried down 1,429.93 1,317.83 295.39 463.02 351.36 744.75
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 150.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 3.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 7.29 10.52 -11.56 8.77 -53.37 -1,117.82
Earnings Per Share(Adj)-Unit Curr 7.29 10.52 - - - -
Book Value 158.56 150.57 10.06 21.77 25.94 4,358.55
Book Value(Adj)-Unit Curr 158.56 150.57 - - - -

Shareholding Pattern

  • Promoter Group

    75.26%

  • Public Share Holding

    22.01%

  • Custodian

    2.73%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 54,255,380 34.47 54,255,380 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 64,200,000 40.79 64,200,000 1
Others 0 0.00 0 0
Sub Total 118,455,380 75.26 118,455,380 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 3,004,811 1.91 3,004,811 33
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 579,401 0.37 579,401 3
Mutual Funds / UTI 15,370,558 9.77 15,370,558 12
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,201,684 3.30 5,201,684 19
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 24,156,454 15.35 24,156,454 67
2] Non Institution
Bodies Corporate 813,235 0.52 813,235 359
Clearing Members 21,871 0.01 21,871 15
Directors of their Relatives 42 0.00 42 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 379,226 0.24 379,226 885
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 370,008 0.24 370,008 1,735
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 488,500 0.31 488,500 1
Individuals holding nominal share capital up to Rs. 1 lakh 8,274,360 5.26 8,274,360 67,165
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 15,669 0.01 15,669 3
Others 794 0.00 794 2
Sub Total 10,490,224 6.66 10,490,224 70,217
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 4,291,930 2.73 4,291,930 1
Total Shares held by Custodians and against which Depository Receipts have been issued 4,291,930 2.73 4,291,930 1
Grand Total ( A + B + C ) 157,393,988 100.00 157,393,988 70,289

Company Background

Akums Drugs & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Akums Drugs & Pharmaceuticals Ltd
  • BSE Code : 34484.0
  • ISIN : INE09XN01023

  • Incorporation Year

    2004

  • Registered Office

    304 Mohan Place LSC Saraswati
    Vihar, Delhi,
    Delhi-110034

  • Telephone

    +91 11 6904 1000

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    DHARAMVIR MALIK

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Akums Drugs & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Akums Drugs 781.45 1,461.70 1,348.74 110.22 6.48
Abbott India 25,878.50 7,217.19 6,929.05 34.06 43.78
Astrazeneca Phar 6,946.95 2,304.07 2,275.58 102.39 27.86
Glaxosmi. Pharma 2,935.35 3,932.76 3,790.20 46.89 58.17
Novartis India 1,614.95 398.23 356.27 40.78 16.64
Cipla 1,389.00 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 636.90 773.53 729.81 59.14 12.51
Amrutanjan Healt 507.20 520.13 502.55 27.17 24.16
Fermenta Biotec. 502.80 474.15 450.25 23.47 18.77
Guj. Themis Bio. 425.00 152.47 150.80 113.64 27.21
Ambalal Sarabhai 43.88 19.52 3.94 81.26 6.77